Agilon Health (AGL) Price & Analysis

Compare

331 Followers

AGL Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.71 - $6.08

Previous CloseN/A

Volume1.09M

Average Volume (3M)16.32M

Market Cap

$530.46M

Enterprise Value$666.19M

Total Cash (Recent Filing)$327.00M

Total Debt (Recent Filing)$41.37M

Price to Earnings (P/E)―

Beta0.34

Next Earnings

Oct 30, 2025

EPS Estimate

-0.15

Last Dividend Ex-Date

Nov 16, 2011

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.25

Shares Outstanding414,423,160

10 Day Avg. Volume6,529,772

30 Day Avg. Volume16,322,794

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.26

Enterprise Value/Revenue0.11

Enterprise Value/Gross Profit-6.02

Enterprise Value/Ebitda-2.24

Forecast

1Y Price Target

$1.21

Price Target Upside-4.72% Downside

Rating ConsensusHold

Number of Analyst Covering15

Bulls Say, Bears Say

Bulls Say

Data AdvancementsAn enhanced data platform that went into effect is expected to provide much improved forecasting accuracy for RAF scores and cost trends for 2026.

Rate HikeThere is a 5.06% rate hike for MA plans, which have expressed plans to set pricing and benefits to rebuild margins in 2026.

Strategic ValueAGL is seen as a strategically valuable asset that could be attractive to buyers, which is supportive of valuation.

Bears Say

Earnings MissThe stock was cut roughly in half as agilon reported a wide 2Q miss, suspended full year 2025 guidance, and announced that CEO Steven Sell had stepped down.

Leadership ChangesCEO Steve Sell stepped down, and AGL is searching for a permanent replacement.

Margin PressuresAGL is being downgraded to Market-Perform due to worse-than-expected margin pressures during 2024 and continued pressure during 2025.

Agilon Health News

Agilon Health downgraded to Market Perform from Outperform at Bernstein

Bernstein analyst Lance Wilkes downgraded Agilon Health (AGL) to Market Perform from Outperform with a price target of...

15d ago

AGL

Agilon Health price target lowered to $1.10 from $2.40 at Jefferies

Jefferies analyst Jack Slevin lowered the firm’s price target on Agilon Health (AGL) to $1.10 from $2.40 and...

20d ago

AGL

Agilon Health price target lowered to $1 from $5 at Baird

Baird lowered the firm’s price target on Agilon Health (AGL) to $1 from $5 and keeps a Neutral...

21d ago

AGL

Agilon Health price target lowered to $1.50 from $4 at Benchmark

Benchmark lowered the firm’s price target on Agilon Health (AGL) to $1.50 from $4 and keeps a Buy...

29d ago

AGL

Agilon Health price target lowered to $1 from $4 at TD Cowen

TD Cowen lowered the firm’s price target on Agilon Health (AGL) to $1 from $4 and keeps a...

29d ago

AGL

Agilon Health downgraded to Neutral from Buy at Citi

Citi downgraded Agilon Health (AGL) to Neutral from Buy with a price target of $1, down from $3...

30d ago

AGL

Balanced Outlook for Agilon Health Amid Market Stability and Challenges

J.P. Morgan analyst Lisa Gill has reiterated their neutral stance on AGL stock, giving a Hold rating on...

10d ago

AGL

Agilon Health Faces Leadership and Performance Challenges Amid Hold Rating

In a report released today, Jack Slevin from Jefferies maintained a Hold rating on Agilon Health, with a...

20d ago

AGL

Agilon Health’s Earnings Call: Challenges and Optimism

Agilon Health Inc (($AGL)) has held its Q2 earnings call. Read on for the main highlights of the...

29d ago

AGL

Agilon Health Faces Uncertainty Amid RAF Challenges and Leadership Changes

Whit Mayo, an analyst from Leerink Partners, reiterated the Hold rating on Agilon Health. The associated price target...

29d ago

AGL

Agilon Health Reports Q2 2025 Results Amid Leadership Change

Agilon Health Inc ( ($AGL) ) has released its Q2 earnings. Here is a breakdown of the information...

29d ago

AGL

Optimistic Buy Rating for Agilon Health Amid Strategic Initiatives and Future Prospects

In a report released today, Bill Sutherland from Benchmark Co. maintained a Buy rating on Agilon Health, with...

1M ago

AGL

Agilon Health’s Hold Rating Amid CEO Resignation and Earnings Shortfall

Needham analyst Matthew Shea has reiterated their neutral stance on AGL stock, giving a Hold rating yesterday. Matthew...

1M ago

AGL

Agilon Health: Hold Rating Amid Leadership Uncertainty and Financial Challenges

William Blair analyst Ryan Daniels has maintained their neutral stance on AGL stock, giving a Hold rating on...

1M ago

AGL

AGL FAQ

What was Agilon Health’s price range in the past 12 months?

Agilon Health lowest stock price was $0.71 and its highest was $6.08 in the past 12 months.

What is Agilon Health’s market cap?

Agilon Health’s market cap is $530.46M.

When is Agilon Health’s upcoming earnings report date?

Agilon Health’s upcoming earnings report date is Oct 30, 2025 which is in 56 days.

How were Agilon Health’s earnings last quarter?

Agilon Health released its earnings results on Aug 07, 2025. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.109 by -$0.141.

Is Agilon Health overvalued?

According to Wall Street analysts Agilon Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Agilon Health pay dividends?

Agilon Health pays a Quarterly dividend of $0.45 which represents an annual dividend yield of N/A. See more information on Agilon Health dividends here

What is Agilon Health’s EPS estimate?

Agilon Health’s EPS estimate is -0.15.

How many shares outstanding does Agilon Health have?

Agilon Health has 414,423,160 shares outstanding.

What happened to Agilon Health’s price movement after its last earnings report?

Agilon Health reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.109. Following the earnings report the stock price went down -1.136%.

Which hedge fund is a major shareholder of Agilon Health?

Currently, no hedge funds are holding shares in AGL

Agilon Health Stock Smart Score

Underperform

Fundamentals

Return on Equity

-60.64%

Trailing 12-Months

Asset Growth

-20.82%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Agilon Health

Agilon Health (AGL) is a healthcare company focused on transforming primary care through partnerships with physician groups. The company operates within the healthcare services sector, providing a value-based care platform that aligns with primary care physicians to improve outcomes for patients and lower healthcare costs. Agilon Health's core service is enabling primary care providers to transition to a value-based care model, supporting them with technology, analytics, and administrative resources.

Agilon Health (AGL) Earnings & Revenues

Historic Earnings Reports

AGL Company Deck

AGL Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Negative

The earnings call highlighted the company's strategic initiatives and improvements in data visibility and quality metrics, but these were overshadowed by disappointing financial results, leadership changes, and the withdrawal of 2025 guidance due to market uncertainties.View all AGL earnings summaries

AGL Stock 12 Month Forecast

Average Price Target

$1.21

▼(-4.72% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","7":"$7","1.75":"$1.75","3.5":"$3.5","5.25":"$5.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.75,3.5,5.25,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.7,1.6846153846153846,1.6692307692307693,1.6538461538461537,1.6384615384615384,1.623076923076923,1.6076923076923078,1.5923076923076922,1.5769230769230769,1.5615384615384615,1.5461538461538462,1.5307692307692307,1.5153846153846153,{"y":1.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.7,1.6623076923076923,1.6246153846153846,1.5869230769230769,1.5492307692307692,1.5115384615384615,1.4738461538461538,1.4361538461538461,1.3984615384615384,1.3607692307692307,1.323076923076923,1.2853846153846153,1.2476923076923077,{"y":1.21,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.7,1.646153846153846,1.5923076923076922,1.5384615384615383,1.4846153846153847,1.4307692307692308,1.376923076923077,1.323076923076923,1.2692307692307692,1.2153846153846155,1.1615384615384614,1.1076923076923078,1.0538461538461539,{"y":1,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.57,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.08,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.67,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.7,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.3,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.9,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.34,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.08,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.93,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.38,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >